The Weill Cornell Medicine Comprehensive Thalassemia Center staff members are committed to the safety and well-being of our patients. For more information about COVID-19, here are links to other sources: the Weill Cornell COVID-19 patient guide, the Centers for Disease Control (CDC) website, the NYC Department of Health website, and the Cooley's Anemia Foundation website.
These sources provide up-to-date information on signs and symptoms, precautions to take, when to quarantine and other important tips. If you have developed a fever, cough, shortness of breath or other respiratory symptoms, please call your provider right away.
The New York Comprehensive Thalassemia Center has provided comprehensive care for individuals with thalassemia for over 30 years, delivering state-of-the-art treatments, pursuing research, and conducting clinical trials to translate scientific advances.
Our clinical thalassemia program is composed of pediatric and adult units with dedicated physicians. A seamless transition program with a dedicated practitioner connects the two units. All of our care is provided at the NewYork-Presbyterian/Weill Cornell Medical Center, an internationally recognized academic hospital and medical research facility.